Recombinant EGFR (Panitumumab Biosimilar) antibody

Catalog No. ABIN7795086

The Mouse Monoclonal anti-EGFR (Panitumumab Biosimilar) antibody has been validated for FACS and in vivo. It is suitable to detect EGFR (Panitumumab Biosimilar) in samples from Human.

Quick Overview for Recombinant EGFR (Panitumumab Biosimilar) antibody (ABIN7795086)

Target: EGFR (Panitumumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This EGFR (Panitumumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), In vivo Studies (in vivo)

Grade: Research Grade

Product Details anti-EGFR (Panitumumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Panitumumab Biosimilar, Endotoxin 0.05 EU/mg

Characteristics: Panitumumab, a fully anti-EGFR (epidermal growth factor receptor, EGF receptor, ErbB-1 and HER1 in humans) human monoclonal antibody, is used for the treatment of refractory EGFR-expressing metastatic colorectal cancer in patients with non-mutated (wild-type) KRAS".

Purification: Protein A or G affinity column

Purity: >95 % by reducing SDS-PAGE

Endotoxin Level: Less than 0.5 EU/mg of protein as determined by LAL method

Immunogen: Human EGFR / ErbB-1 / HER1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: > 3 mg/mL

Storage: 4 °C,-20 °C

Storage Comment: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Target Details for EGFR (Panitumumab Biosimilar)

Target: EGFR (Panitumumab Biosimilar)

Alternative Name: Panitumumab Biosimilar

Target Type: Biosimilar